{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:50:14Z","timestamp":1761058214165},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1973,3,1]],"date-time":"1973-03-01T00:00:00Z","timestamp":99792000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digest Dis Sci"],"published-print":{"date-parts":[[1973,3]]},"DOI":"10.1007\/bf01071975","type":"journal-article","created":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T17:04:50Z","timestamp":1107277490000},"page":"213-222","source":"Crossref","is-referenced-by-count":44,"title":["Methyldopa hepatitis"],"prefix":"10.1007","volume":"18","author":[{"suffix":"Jr","given":"Anastacio M.","family":"Hoyumpa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alastair M.","family":"Connell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1126\/science.131.3417.1890","volume":"131","author":"JA Oates","year":"1960","unstructured":"Oates JA, Gillespie L Jr, Undenfriend S, Sjoerdsma A: Dicarboxylase inhibitor and blood pressure reduction by alpha-methyldopa 3,4,dihydroxy-DL-phenylalanine. Science 131: 1890?1891, 1960","journal-title":"Science"},{"key":"CR2","first-page":"577","volume-title":"Pharmacologic Basis of Therapeutics","author":"LS Goodman","year":"1970","unstructured":"Goodman LS, Gilman A: Pharmacologic Basis of Therapeutics. Fourth edition. New York, The MacMillan Company, 1970, pp 577?579","edition":"Fourth edition."},{"key":"CR3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/01.CIR.25.2.281","volume":"25","author":"L Gillespie","year":"1962","unstructured":"Gillespie L, Oates JA, Crout JR, Sjoerdsma A: Clinical and chemical studies with ?-methyldopa in patients with hypertension. Circulation 25:281?291, 1962","journal-title":"Circulation"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0140-6736(62)91247-3","volume":"1","author":"ROH Irvine","year":"1962","unstructured":"Irvine ROH, O'Brien KP, North JDK: Alphamethyldopa in treatment of hypertension. Lancet 1:300?303 1962","journal-title":"Lancet"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0140-6736(62)91782-8","volume":"1","author":"RIS Bayliss","year":"1962","unstructured":"Bayliss RIS, Harvey-Smith EA: Methyldopa in the treatment of hypertension. Lancet 1:763?768, 1962","journal-title":"Lancet"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/bmj.2.5298.156","volume":"2","author":"D Daley","year":"1962","unstructured":"Daley D, Evans B: Another hypotensive agentmethyldopa. Br Med J 2:156?158 1962","journal-title":"Br Med J"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/bmj.1.5324.151","volume":"1","author":"M Hamilton","year":"1963","unstructured":"Hamilton M, Kapelman H: Treatment of severe hypertension with Methyldopa. Br Med J 1:151?155, 1963","journal-title":"Br Med J"},{"key":"CR8","first-page":"99","volume":"91","author":"MS Klapper","year":"1963","unstructured":"Klapper MS, Richard L: A clinical study with methyldopa as an anti-hypertensive agent. Med Times 91:99?106, 1963","journal-title":"Med Times"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1001\/jama.1963.03700210050008","volume":"184","author":"SG Sheps","year":"1963","unstructured":"Sheps SG, Schirger A, Osmundson PJ, Fairbairn JF: Methyldopa for treatment of hypertension. JAMA 184:616?621, 1963","journal-title":"JAMA"},{"key":"CR10","first-page":"171","volume":"1","author":"PJ Cannon","year":"1963","unstructured":"Cannon PJ, Laragh JA: Treatment of hypertension with alpha-methyldopa. Pharmacotherapia 1:171?184, 1963","journal-title":"Pharmacotherapia"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1001\/jama.1963.63710030042021d","volume":"186","author":"J Conway","year":"1963","unstructured":"Conway J, Zweifler AJ, Julius S: The place of methyldopa in the treatment of severe hypertension. JAMA 186:266?268, 1963","journal-title":"JAMA"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/01.CIR.28.2.165","volume":"28","author":"MH Weil","year":"1963","unstructured":"Weil MH, Barbour BH, Chesne RB: Alphamethyldopa for the treatment of hypertension. Circulation 28:165?174, 1963","journal-title":"Circulation"},{"key":"CR13","unstructured":"Foltz EL: cited by Weil et al"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/00325481.1963.11694805","volume":"34","author":"D Horwitz","year":"1963","unstructured":"Horwitz D, Sjoerdsma A: Use of two enzyme inhibitors in hypertension therapy. Postgrad Med 34:140?144, 1963","journal-title":"Postgrad Med"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1056\/NEJM196410012711402","volume":"271","author":"JM Colwill","year":"1964","unstructured":"Colwill JM, Dutton AM, Morrissey J, Yu PN: Alpha-methyldopa and hydrochlorothiazide: A controlled study of their effectiveness as antihypertensive agent. N Engl J Med 271:696?703, 1964","journal-title":"N Engl J Med"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/00000441-196412000-00002","volume":"248","author":"Y Morin","year":"1964","unstructured":"Morin Y, Turmel L, Fortier J: Methyldopa: clinical studies in arterial hypertension. Am J Med Sci 248:633?639, 1964","journal-title":"Am J Med Sci"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/0002-8703(65)90242-5","volume":"69","author":"JW Leonard","year":"1965","unstructured":"Leonard JW, Gifford RW, Humphrey DC: Treatment of hypertension with methyldopa alone or combined with diuretics and\/or guanethidine: A report of 63 cases. Am Heart J 69:610?618, 1965","journal-title":"Am Heart J"},{"key":"CR18","first-page":"238","volume":"95","author":"C Vorburger Von","year":"1964","unstructured":"Von Vorburger C, Luthi H, Reubi F: Erfahrunger mit 1-a-Methyldopa (aldomet) in der hypertonie-Sprechstunde. Schweiz Med Wochenschr 95:238?246, 1964","journal-title":"Schweiz Med Wochenschr"},{"key":"CR19","first-page":"13","volume":"34","author":"BL Gilmore","year":"1965","unstructured":"Gilmore BL, Freis ED: Methyldopa in the treatment of hypertension. Med Ann DC 34:13?18, 1965","journal-title":"Med Ann DC"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0033-0620(65)80019-6","volume":"8","author":"CT Dollery","year":"1965","unstructured":"Dollery CT: Methyldopa in the treatment of hypertension. Prog Cardiovasc Dis 8:278?289, 1965","journal-title":"Prog Cardiovasc Dis"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-65-4-657","volume":"65","author":"WM Smith","year":"1966","unstructured":"Smith WM, Bachman B, Galante J, Hanowell EG, Johnson WP, Koch CE Jr, Korfmacher SD, Thurm RH, Bromer L: Cooperative clinical trial of alpha-methyldopa: III. Double-blind control comparison of alpha-methyldopa and chlorothiazide and chlorothiazide and rauwolfia. Ann Intern Med 65:657?671, 1966","journal-title":"Ann Intern Med"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(66)92448-2","volume":"2","author":"SG Cotton","year":"1966","unstructured":"Cotton SG: Methyldopa and haemolytic anemia. Lancet 2:165, 1966","journal-title":"Lancet"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/cpt196782224","volume":"8","author":"D Horwitz","year":"1967","unstructured":"Horwitz D, Pettinger WA, Orvis H, Thomas RE, Sjoerdsma A: Effects of methyldopa in fifty hypertensive patients. Clin Pharmacol Ther 8:224?234, 1967","journal-title":"Clin Pharmacol Ther"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0140-6736(70)91327-9","volume":"2","author":"WE Gibb","year":"1970","unstructured":"Gibb WE, Malpas JF, Turner P, White RJ: Comparison of bethanidine, ?-methyldopa and reserpine in essential hypertension. Lancet 2:275?277, 1970","journal-title":"Lancet"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/bmj.1.5740.75","volume":"1","author":"A Heffernan","year":"1971","unstructured":"Heffernan A, Carty A, O'Malley K, Bugler J: A within-patient comparison of debrisoquine and methyldopa in hypertension. Br Med J 1:75?78, 1971","journal-title":"Br Med J"},{"key":"CR26","first-page":"1897","volume":"67","author":"Z Zarday","year":"1967","unstructured":"Zarday Z, Rosenthal WS, Wolff FW: Severe liver toxicity after methyldopa. NY State J Med 67:1897?1899, 1967","journal-title":"NY State J Med"},{"key":"CR27","first-page":"666","volume":"97","author":"C Perret","year":"1967","unstructured":"Perret C, Enrico JF, Montani S, Pappalardo G: Le role de la necrose hepatique dans la pathogenese de l'acidose lactique spontanee. Schweiz Med Wochenschr 97:666?671, 1967","journal-title":"Schweiz Med Wochenschr"},{"key":"CR28","first-page":"5","volume":"1","author":"ER Williams","year":"1967","unstructured":"Williams ER, Khan MA: Liver damage in patients on methyldopa. J Ther Clin Res 1:5?7, 1967","journal-title":"J Ther Clin Res"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/01.CIR.40.4.589","volume":"40","author":"SG Elkington","year":"1969","unstructured":"Elkington SG, Schreiber WM, Conn HO: Hepatic injury caused byL-alpha-methyldopa. Circulation 40:589?595, 1969","journal-title":"Circulation"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/bmj.1.5646.780","volume":"1","author":"R Wyburn-Mason","year":"1969","unstructured":"Wyburn-Mason R, Anastassiades C: Jaundice and methyldopa. Br Med J 1:780, 1969","journal-title":"Br Med J"},{"key":"CR31","first-page":"218","volume":"25","author":"ML Wong","year":"1971","unstructured":"Wong ML: Hepatocellular damage due to methyldopa. Med J Malaya 25:218?219, 1971","journal-title":"Med J Malaya"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/BF02239316","volume":"16","author":"JE Tysell","year":"1971","unstructured":"Tysell JE, Knauer CM: Hepatitis induced by methyldopa (aldomet): Report of a case and a review of the literature. Am J Dig Dis 16:849?855, 1971","journal-title":"Am J Dig Dis"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/BF02235014","volume":"16","author":"M Eliastam","year":"1971","unstructured":"Eliastam M, Holmes AW: Hepatitis, arthritis and lupus cell phenomenon caused by methyldopa. Am J Dig Dis 16:1014?1018, 1971","journal-title":"Am J Dig Dis"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/archinte.1965.03860140008003","volume":"115","author":"H Popper","year":"1965","unstructured":"Popper H, Rubin E, Gardiol D, Schaffner F, Paronetto F: Drug-induced liver disease. Arch Intern Med 115:128?136, 1965","journal-title":"Arch Intern Med"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1056\/NEJM197110072851501","volume":"285","author":"TB Reynolds","year":"1971","unstructured":"Reynolds TB, Peters RL, Yamada S: Chronic active and lupoid hepatitis caused by a laxative, oxyphenisatin. N Engl J Med 285:813?820, 1971","journal-title":"N Engl J Med"}],"container-title":["The American Journal of Digestive Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01071975.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01071975\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01071975","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T06:07:21Z","timestamp":1556604441000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01071975"}},"subtitle":["Report of three cases"],"short-title":[],"issued":{"date-parts":[[1973,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1973,3]]}},"alternative-id":["BF01071975"],"URL":"https:\/\/doi.org\/10.1007\/bf01071975","relation":{},"ISSN":["0002-9211","1573-2568"],"issn-type":[{"value":"0002-9211","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[1973,3]]}}}